BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6794039)

  • 1. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfanilic acid: behavioral change related to azo food dyes in developing rats.
    Goldenring JR; Batter DK; Shaywitz BA
    Neurobehav Toxicol Teratol; 1982; 4(1):43-9. PubMed ID: 6803178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
    Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
    Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine].
    Takasuna M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):315-21. PubMed ID: 2123587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Kenny AM; Schneider MB; Baden DR; Pfeiffer RF; Murrin LC
    Neurology; 1986 Mar; 36(3):400-4. PubMed ID: 3081831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-OHDA induced effects upon the acquisition and performance of specific locomotor tasks in rats.
    Watson M; McElligott JG
    Pharmacol Biochem Behav; 1983 Jun; 18(6):927-34. PubMed ID: 6412249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats.
    Carey RJ
    Pharmacol Biochem Behav; 1983 Feb; 18(2):273-6. PubMed ID: 6403950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.